2017 is coming to a close, and unfortunately it didn’t offer up as many highlights when it comes to marijuana as 2016. Last year, we saw three states legalize cannabis recreationally (California, Maine and Massachusetts), and a fourth came up just short (Arizona). This year, the biggest story was that New Jersey elected someone who’s…
Government has upped THC levels of the drug from 2% to 9% Humans have been getting high on marijuana for millennia, and there has never been a recorded case of a fatal overdose. That record appeared to be in peril earlier this week, following reports that an 11-month-old in Colorado died last year following exposure to THC,…
Government has upped THC levels of the drug from 2% to 9% Five months after legalising recreational marijuana, there are more than 16,000 Uruguayans registered to buy the drug from pharmacies, up from 5,000 users in July. People in Uruguay can also grow plants at home, or become a member of a local Cannabis Club…
There is an explosion in the number of labs analyzing cannabinoids in marijuana (Cannabis sativa L., Cannabaceae) but existing methods are inefficient, require expert analysts. The objective of this work was to develop and validate an accurate method for analyzing cannabinoids in cannabis raw materials and finished products that is more efficient and uses fewer toxic solvents. This is a significant improvement over previous methods and is suitable for a wide range of applications including regulatory compliance, clinical studies, direct patient medical services, and commercial suppliers.
Cannabidiol (CBD)-based treatments for several diseases, including Tourette’s syndrome, multiple sclerosis, epilepsy, movement disorders and glaucoma, are proving to be beneficial and the scientific clinical background of the drug is continuously evolving. This study demonstrated the safety and tolerability of CBD-rich hemp oil and the primary efficacy endpoint. Randomized controlled trials are warranted to characterize the safety profile and efficacy of this compound.
The new bill sets out the proposed rules and regulations An act to amend the Drug Dependence (Treatment not Imprisonment) Act of 2015 will be discussed in Parliament today, and could determine the future of medical cannabis in Malta. The bill, which will be undergoing its second reading in a plenary session in Parliament this…
The Labour-led Government will act on making medical cannabis more accessible next week. But instead of supporting an existing Bill in the House, the Government will introduce its own legislation. Labour campaigned on making medicinal cannabis available for people with terminal illness or in chronic pain, promising to introduce the legislation within its first 100…